Experimental primary cytomegalovirus infection in pregnancy: Timing and fetal outcome

1983 ◽  
Vol 145 (1) ◽  
pp. 56-60 ◽  
Author(s):  
Mary L. Kumar ◽  
Sandra L. Prokay
2006 ◽  
Vol 195 (6) ◽  
pp. S52
Author(s):  
Baruch Feldman ◽  
Yoav Yinon ◽  
Michal Tepperberg-Dikawa ◽  
Eyal Schiff ◽  
Shlomo Lipitz

BMJ ◽  
1986 ◽  
Vol 292 (6522) ◽  
pp. 718-720 ◽  
Author(s):  
H Stern ◽  
G Hannington ◽  
J Booth ◽  
D Moncrieff

2015 ◽  
Vol 36 (4) ◽  
pp. 179 ◽  
Author(s):  
Maria Grazia Revello ◽  
Valentina Frisina ◽  
Giovanna Oggè ◽  
Alessia Arossa ◽  
Milena Furione

In the absence of a cytomegalovirus (CMV) vaccine, other strategies for prevention of primary infection in pregnancy should be considered. Behavioural interventions have been reported to significantly decrease seroconversion rate among seronegative pregnant women. We report here on a recently completed controlled study in which seronegative women at high risk of infection because of close contacts with children <36 months, were identified and informed about risky and protective behaviours. Informed women seroconverted at a significantly lower rate than non-informed women.


1987 ◽  
Vol 7 (2) ◽  
pp. 46 ◽  
Author(s):  
S. Stagno ◽  
R. F. Pass ◽  
G. Cloud ◽  
W. J. Britt ◽  
R. E. Henderson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document